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Dr Lawrence Cohn (Boston, Mass). I have no disclosures.
Dr Suri, an excellent presentation of a complicated subject empha-
sizing last year’s article from the Cleveland Clinic, which indicates
that robotic surgery can be done well in good centers. You pre-
sented some provocative results. I am going to ask you a few tech-
nical questions, and then I will save my final philosophical
question for the end.
There are 2 things I would like to know from a technical point of
view. In the article you said all knots are tied by the assistant sur-
geon at the operating table. I thought the surgeon operating the
robot did the knot tying.
Dr Suri. I actually wrote that the knots are tied by the bedside
surgeon. If I can somehow further clarify it in the article, I would
be happy to do so. But you bring up a good point, Dr Cohn, it is our
opinion that a robotic program aiming to duplicate gold standard,
proven open repair techniques must use an experienced bedside
surgeon. Others have also followed this model, such as Drs Siwek
and Chitwood. Some groups have used trained physician assis-
tants, such as Dr Murphy, which has worked well for him. But
again, I can clarify that 2 surgeons (my partner, Dr Harold Bur-
khart, and I) work together in our repair robotic program.
Dr Cohn. Tell us why you used the same size ring for every
patient.
Dr Suri. Good question. The mitral repair techniques that I
have discussed today have been used for 20 to 30 years at Mayo
Clinic. Both the rationale for the adoption of these techniques
and the durability of the approaches have been published in prior
reports. Drs Schaff and Orszulak were really the pioneers of the
single-sized annuloplasty band. They obtained pathologic data
showing that in normal patients, the average mitral annular cir-
cumference is 10 cm, further observing that the posterior two
thirds of the mitral annulus dilated in those with chronic degener-
ative MR. I understand that a discussion occurred between Drs
Schaff and Dorszulak in the operating room lounge one day, at
which point they settled on using a 63-mm band anchored between
left and right fibrous trigones. It has worked well over the interven-
ing 30 years, proving to be associated with excellent long-term du-
rability and freedom from reoperation. We recently publishedThe Journal of Thoracic and Caa 3-dimensional echo confirmation of the anatomic rationale for
using a flexible posterior annuloplasty band to correct posterior an-
nular dilation associated with leaflet prolapse where the anterior
intertrigonal distance is generally fixed.
Dr Cohn. Next, you talk about the learning curve, which is ex-
tremely important. In your experience, how many months did it
take you from the start of your robotic program to reduce the learn-
ing curve?
Dr Suri.That is an important question. Our opinion is that a sur-
geon should become facile with open mitral repair techniques,
demonstrating high repair rates and low MR recurrence before
venturing into the closed chest milieu. After initiation of our ro-
botic program at Mayo Clinic, it seems that we encountered
a ‘‘learning curve shoulder’’ at approximately 50 cases. After
that, we noted decreases in crossclamp, bypass, and operating
room times. We also documented both cost-savings and certain
patient benefits associated with improvements in operating room
efficiency. Once patients undergoing robotic surgery are extubated
on the operating room table, it is impressive how rapidly they
proceed through the postoperative period and return to normal
activities after dismissal from the hospital.
Dr Cohn. I assume from what you have just said that there are
cost-savings, and I am sure you can document that because of the
shorter hospital stays.
DrSuri.That is correct. Those data are currently being drafted for
publication and will hopefully find a compassionate editorial ear.
Dr Cohn. One of the things that validated our original series of
mini-mitrals, which was a lower mini-sternotomy 14 years ago,
was that patients in a blinded fashion were found to recover faster
and return to work faster, something that patients really like. Is this
true in your series?
Dr Suri. Yes. I have read your publications, and we owe you
a tremendous debt for the pioneering work you have done in this
field, Dr Cohn. We concur with your opinion that patients return to
normal daily activities more rapidly using less-invasive approaches.
Dr Cohn. Final question, and possibly the most important one.
Who should perform robotic mitral valve (MV) surgery? As I in-
dicated, you have a superb experience at the Mayo Clinic, which
is numbering more than 250 MV repairs a year. But one of the
articles you discussed in your presentation by Gammie and
colleagues suggested that the majority of the Society of Thoracic
Surgeons see 5 to 10 MVs per year.
My personal belief, as is yours, is that you have to really know
how to do MV repair before you use this kind of technique, which
is excellent but more complicated. Would you like to comment on
that?
Dr Suri. This is an important point. It is the topic of debate
among members of our societies and is ultimately a question that
will need to be resolved in those forums. That said, there are recent
publications pointing to an 80 to 100 MV repair-per-year volume
prerequisite before a surgeon and surgical team (a) become effica-
cious in performing reproducible repair for all categories of leaflet
prolapse and thus (b)move forward in attempting to duplicate these
same repairs via less invasive incisions, particularly via robotic
assistance. Guidelines for the adoption of robotic assistance in car-
diac surgery are currently being drafted and will be surfacing in the
next year or two, addressing these key points.
Dr Cohn. Thank you.rdiovascular Surgery c Volume 142, Number 5 977
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DDrThierryMesana (Ottawa,Ontario, Canada). Nice presenta-
tion and great results. I have a question for you regarding the pathol-
ogy that you find. How many of these bileaflets or even posterior
leaflets were really myxoid degeneration, severe Barlow disease?
Dr Suri. Dr Schaff has shown that oftentimes bileaflet disease
can be corrected with an annuloplasty band alone. The incidence
of Barlow’s type myxomatous disease was obviously much higher
in our bileaflet group, both open and robotic. We have a particular
technical approach we use at Mayo Clinic for these patients, con-
sisting of triangular resection of the posterior leaflet and placement
of polytetrafluoroethylene (Gore-Tex;WLGore&Associates, Inc,
Flagstaff, Ariz) neochords to the anterior leaflet plus standard-
length 63-mm flexible posterior annuloplasty band. I think that
is what you are getting at?
DrMesana.And the fact you were doing this robotically didn’t
change this technique?
Dr Suri. Correct—every stitch and each annuloplasty band are
placed equivalently when comparing open and robotic MV repairs
atMayoClinic.Wedonotmodify standardopenMVrepair techniques
when tackling even the most complex valves using robotic assistance.
Dr Francis Wells (Cambridge, United Kingdom). My question
is not so much about technique, which you seem to have mastered
extremely well, but returning to the cost. We do approximately 200
MV repairs a year, or I do, one surgeon, average length of stay 5
days, and doing it open, the cost is well known and acceptable.
What is your added cost for using the robot in terms of disposables
and primary investment, because surely you have to add that to
your overall cost per patient?
Dr Suri. That is something we have been particularly interested
in since the initiation of our robotic mitral repair program. The con-
founder in addressing this question directly is that there has been
a concurrent program to decrease overall costs by 20% during the
same period, so there really have been 2 moving targets, an effort
to optimize the cost efficiencyof robotic repairwithin the larger con-
text of overall cost reductionwithin cardiac surgery atMayoClinic.
I can tell you that from our preliminary analysis examining pro-
pensity-matched open versus robotic MV repair, it appears that
from the time of walking in the hospital door to walking out, costs
are equivalent. This includes the amortized cost of robotic equip-
ment, disposables, and all other ‘‘bucketed’’ hospital expenses.We
are currently performing the final analyses in that study and will be
submitting a manuscript in the near future.
DrRalphDamiano (St Louis,Mo). DrSuri, a superbpresentation
and congratulations on fantastic results. I have 2 quick questions.
First, the advantages of the robotic approach over the sternotomy ap-
proach were mainly shorter extubation times, lower ventilation
times, and shorter length of stay. Is this advantage really just a result
of the smaller incision? Do you really need robotic assistance? That
is, can you compare it with a cohort, which I think would be more
interesting, of patients undergoing a mini-thoracotomy performed
with standard instruments? Do you have any data on that?
My second quick question is regarding the patients with bileaf-
let disease. What percent of these patients actually had a specific
procedure done to the anterior leaflet?
Dr Suri.Myownview is thatwe shouldn’t be arguing amongour-
selves regarding incisional approach. The debate is really akin to
a long-needle driver Dr Schaff likes to use or a short one that another
colleague might use; the robot is a technical instrument to perform978 The Journal of Thoracic and Cardiovascular Surgthe same operation through a different incision. We were recently
at Dr Adams’Mitral Conclave in NewYork; it was a fantastic meet-
ing, and we discussed this topic at length. It struckme, however, that
we often argue among ourselves regarding supremacy of one inci-
sion over another, when really we might best expend our energy en-
suring accurate interpretation of EVEREST II trial data upholding
superior outcomes of contemporary surgical MV repair for degener-
ative disease of clip technology. We should be offering patients the
best technical outcome, and, in our view, that is surgical repair. Fur-
ther, we are not claiming superiority of sternotomy, thoracotomy, or
robotic approaches. We suggest that if repair is performed using
proven techniques known to be associated with excellent long-
term survival and durability, outcomes should be the same even
when carried out via smaller incisions to address patient demand.
In regard to how many anterior leaflets were addressed, I can tell
you that overall, dependingon the cohort, 20% to25% receivedpoly-
tetrafluoroethylene (Gore-Tex) neochords. Now, at our institution,
MVs are repaired with slight stylistic differences while still using
the same techniques.What do Imean by that, well, commissural pro-
lapse for instance, might be addressed by one surgeon by inserting
a neochord, and another might place a commissural placation stitch.
So although those subtle distinctions get a little muddy when per-
forming a retrospective analysis, I can say that true anterior leaflet
disease is generally corrected with polytetrafluoroethylene (Gore-
Tex) neochords atMayoClinic viabothopenand robotic approaches.
Dr David Adams (New York, NY). If you can clarify, because I
do think there is one confounder here. Your bias in the robotic
group, it sounds like you had a bias to extubate on the table. I won-
der if your anesthetic management was really the same between
these 2 groups, because your crossclamp time in the sternotomy
group is 30 minutes, which is phenomenal. My guess is part of
this length of stay issue may just be your protocol differences be-
tween robotics and standard operations.
Congratulations on your outstanding results in robotics. It is
showing again that masterly trained people that really put their
head to it can learn this stuff.
Dr Suri.We found that after the adoption of a port-access plat-
form, our teams were so motivated by the early successes and see-
ing patients doing well that they sought to ‘‘advance the game,’’ so
to speak, by further improving efficiency within the system. Our
anesthesiologists were particularly impressive. They took the
lead in deciding to place a paravertebral block in robotic cases
prior to anesthetic induction, which subsequently facilitated extu-
bation of patients on the operating room table with no or minimal
pain. In fact, I remember an academic cardiologist, head of a pro-
gram at another institution, who emerged from anesthetic and
calmly asked for a stethoscope to listen to his newly repaired
MVon the operating room table—true story. We have found these
adjunctive anesthetic techniques further facilitate rapid de-escala-
tion in acuity of care and expedite the postoperative recovery path-
way. We will be writing about these anesthetic adjuncts soon.
So you are correct, Dr Adams, there are currently differential
anesthetic protocols being used among robotic and open repair
cases. I would like to reiterate a prior statement, however, no
one is claiming superiority of one approach over another. We are
merely trying to establish a contemporary surgical standard for de-
generativeMV repair against which less-effective emerging percu-
taneous therapies might be judged.ery c November 2011
